SIGA - SIGA Technologies Inc
IEX Last Trade
9.02
-0.160 -1.774%
Share volume: 526,923
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$9.18
-0.16
-1.74%
Fundamental analysis
40%
Profitability
61%
Dept financing
9%
Liquidity
75%
Performance
17%
Performance
5 Days
-4.85%
1 Month
-8.60%
3 Months
21.37%
6 Months
95.24%
1 Year
118.16%
2 Year
-28.48%
Key data
Stock price
$9.02
DAY RANGE
N/A - N/A
52 WEEK RANGE
$3.66 - $12.83
52 WEEK CHANGE
$1.25
DIVIDEND
$0.60
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Phillip Louis Gomez III
Region: US
Website: siga.com
Employees: 85
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: siga.com
Employees: 85
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
Recent news